SlideShare a Scribd company logo
CASE PRESENTATION ON
AUTO-IMMUNE
HEMOLYTIC ANEMIA
BY
M.HEMA SREE
PHARM D 4TH YEAR
INTRODUCTION
DEFINITION
• Autoimmune hemolytic anemia[AIHA] is characterized by an
abnormal production of auto antibodies[Ig G,M.E,A] that bind
to Antigens on the erythrocyte surface. These antibodies then
lead to destruction of RBC’s thus shortening their life span.
• Red cell lifespan may decrease to 30days.
CLASSIFICATION
• Warm AIHA
• Cold AIHA – Cold Agglutinin Syndrome
Paroxysmal Cold Hemoglobinuria
• Mixed type AIHA
• Drug Induce Immune hemolytic anemia
WARM AIHA
• In this warm AIHA, the autoantibodies attach to & destroy the
RBC at temperature ≥ to 37 degrees celcius.
• More common among women.
• MECHANISM OF DESTRUCTION: Due to Extravascular
hemolysis
• Associated with development of Ig G
• May be due to primary or secondary etiology
Primary – idiopathic
Secondary –due to underlying disease[eg: lymphoproliferative
or autoimmune disorders]
COLD AIHA
• The autoantibodies become most active and attack RBC below
normal body temperature.
• Mainly effects in middle aged or elderly.
• Due to development of IgM & G antibody.
• Either primary or secondary in etiology
• MECHANSIM OF DESTRUCTION: Extravascular and Intravascular
hemolysis
COLD AGGLUTINATION SYNDROME – IgM antibodies
• Hemolysis – extravascular
• Causes – mononucleosis infections, lymphoproliferative disorders)
PAROXYSMAL COLD HEMOGLOBINURIA : Ig G antiodies
• Intravascular hemolysis
• Occurs due to infections( sypihils, pneumoniae, measles, infulenza)
also due to vaccines
MIXED TYPE AIHA
• Features similar to WAIHA & CAS
• Both IgG & C3d[activated by IgM cold Ab] are detected
DRUG INDUCED AIHA
• Antibodies directed against or one of its metabolites
• All may involve IgG &C3
• Eg: Pencillin , Cephalosporins , Quinidine , Methyldopa
PATHO or IMMUNOLOGIACL VIEW
• WAIA
IgG binds to RBC surface antigens
This drives monocytes and macrophages to
grab & pick off portions of RBC membrane
RBC becomes spherocytes
Destructed in spleen
Extravascular hemolysis
COLD AGGLUTINATION DISEASE
In cold temperature, IgM binds to
polysaccharide region of glycoprotein on RBC
surface
This triggers complement system to lyse RBC
If complement system fails to form membrane
attack complex, complement proteins deposit
on RBC surface
This opsonisation enhances RBC phagocytosis
in liver, spleen & lungs
Extravascular hemolysis
PAROXYSMALCOLD HEMOGLOBINURIA
During infections , microbes trigger formation of
Abs which react with p antigen of RBC surface
These polyclonol anti-P autoAb binds to P-Ag of
RBC in cold temp
Activation of complement system,
Lysis of RBCs
Intravascular hemolysis
CLINICAL MANIFESTATIONS
• Paleness of skin
• Fatigue
• Fever and chills
• Confusion
• Lightheadedness
• Weakness
• Body ache
COMMON SYPTOMS LESS COMMON SYMPTOMS
• Dark urine
• Yellowing of skin and eyes
• Increased HR
• Enlarged spleen
• Enlarged liver
DIAGNOSIS
• CBC : Hb - decreased
Hematocrit – decreased
Reticulocytes- increased
• peripheral smear – microcytic, anisocytosis , spherocytes ,
hypochromic , poikilocytosis
• Other lab data : elevated LDH, indirect bilirubin and
decreased haptoglobin
• Direct coombs test
TREATMENT
WARM AHIA
• Folic acid supplements
• Corticosteriods like
prednisolone[1-
1.5mg/kg/day]
• Immunoglobulins like
rituximab, azathioprine
etc..
• If ineffective splenectomy
considered
• Blood transfusion
• Splenectomy
COLD AIHA
• Removal of underlying
disease.
• Use antibiotics like pencillin
in case of infections
• Rituximab is given majorly
• Avoid cold weather an cold
drinks
• Blood transfusion
• Splenectomy
PATIENT
PROFILE FORM
DEMOGRAPHIC DETAILS
• Patient name: XYZ
• Age: 21 Years
• Gender: Female
• Height:165cm
• Weight: 85kg
• BMI: 31.2Kg/sqmm[over weight]
• IP No:472890
• Dept: General medicine-554
• DOA:11/NOV/19
• DOD:14/NOV/19
COMPLAINTS
• B/L knee pain
• Mild swelling at knees
• Chills
• Headache
• Weakness and pale skin
• Fatigue
HISTORY
• Past medical history: Hypothyroid
• Past medication history: Tab Thyronorm 100mcg
PROVISIONAL DIAGNOSIS
AUTO-IMMUNE
HEMOLYTIC ANEMIA..?
Osteoarthritis..?
Osteonecrosis..?
Jaundice..?
DAY TO DAY ASSESMENT
DAY-1
• O/E patient conscious , coherent and afebrile
• c/o bilateral knee pain,
Headache(+),
Generalised weakness
• Hypothyroid (℞ on 1oomcg thyronorm)
• No organomegaly and lymphadenopathy
• Patient was evaluated outside and given Tab HCQS -400mg od
3 days
• Beta thalassemia minor-negative
Day 2
• B/L Knee pain
• Weakness reduced
• No other issues
• T.GEMFOS[Risedronate]-35mg/week on empty stomach with 1full
glass of water, Don’t EAT, LIE DOWN, BEND for 2hrs, can walk and sit
Day -3
• B/L Knee pain reduced
No weakness
No headache
• Can be discharged tomorrow
Day -4
• DISCHARGE RECOMMENDATIONS
1. Consider treatment with biphosphonates and calcium and
vitamin D - Tab SHELCAL 5OOmg OD
2. Tab GEMFOS 35mg/Week
3. Tab WYSOLONE 1.5mg/alternate day
4. No squatting, strain, inclines, walking on uneven surface
5. Reduce and maintain weight
6. Physiotherapy
7. Continue Tab THYRONORM 100mcg OD
8. Tab. FOLACIN 800mcg OD
PHYSICAL EXAMINATION
VITALS
• RR -19/min
• BP -110/7OmmHg
• SPO2 – 98%
• Respiratory system – BAE (+)
No added sounds
• CNS – no focal deficits
• CVS –S1S2 Heard
• LIMBS – distal pulses (+)
• ABDOMEN – non-tender, soft
LABORATORY VALUES
PARAMETER RESULT NORMAL RANGE
Haemoglobin 10.10gms% 12-16gms%
RBC 3.59million/cumm 4.5-5.5 million/cumm
PCV 37% 35-48%
Platelets 3.63lakhs/cumm 1.5-4.5lakhs/cumm
WBC 6,720cells/cumm 4k-10kcells/cumm
Hematocrit 12% 37-48%
Reticulocytes 3.76% 0.5-2.5%
ESR 25mm 0-20mm
LDH Total 197 IU/L 120-246 1U/L
PARAMETER RESULT NORMAL RANGE
T.Bilirubin 0.50mg/dl 0.1-1.2 mg/dl
BC.Conjugated 0.00mg/dl 0-0.35mg/dl
BC.unconjugated 0.99mg/dl 0-0.65mg/dl
T.Protein 7.20g/dl 6.3-7.9g/dl
Albumin 4.10g/dl 3.5-5.0g/dl
Gobulin 3.10g/dl 2-3.5g/dl
A/G Ratio 1.30 Approx 1
GGT 25.00 IU/L 8-62 IU/L
ALP 64.OO IU/L 40-129 IU/L
SGOT 26 IU/L 5-40 IU/L
SGPT 23 IU/L 5-40IU/L
IMMUNOSEROLOGY
• Rheumatoid factor assay : <8.6 IU/L [ normal : <121 IU/L]
PERIPHERAL SMEAR
• RBC Morphology : Microcytic Hypochromic with Anisocytosis,
spherocytes
• WBC : normal in count & disturbances
• PLATELET : Adequate
BIOCHEMISTRY
LUPUS ANTICOAGULANT
• DIL RUSSEL VIPER VEN TIME : 58.00 sec
• DRVVT CONTROL : 49.00 sec
• DRVVT:DRVVTC Ratio – 1.18 sec
• REFERENCE VALUE [ <1.30sec]
URINE
• Total Input- 1300ml
• Total Output – 1200ml
MRI OF KNEE JOINTS
• Findings : few irregular areas of altered signal intensity with T1
isointense &peripheral hyperintense rim, hyperintense on T2
weighed fat
• Marrow edema noted in femoral condyle with ill defined
margins of sub-chondral altered signal area
• Findings suggestive of medullary infracts in distal femur with
sub-chondral osteonecrosis in medial femoral condyle
• Mildly reduced fibro femoral joint space with reduced articular
cartilage thickness[grade-2]
MEDICATION CHART
S.
no
BRAND
NAME
GENERIC NAME DOSE FREQ ROA D
1
D
2
D
3
1 T.SHELCAL Ca++ with vit D3 500mg OD PO + + +
2 T.GEMFOS Risedronate 35mg OD PO - + +
3 T.
WYSOLONE
Prednisolone 1.5 mg Alterna
te day
PO + - +
4 T.FOLACIN
800
Folic acid 800mc
g
OD PO + + +
5 T.THYRONOR
M
levothyroxine 100mc
g
OD PO + + +
SOAP ANALYSIS
SUBJECTIVE EVIDENCE
• Fatigue
• Chills
• Headache
• Weakness
• Pale skin
OBJECTIVE EVIDENCE
• Haemoglobin- 10.10gms% [low]
• Hematocrit -12%[low]
• Reticulocytes - 3.76%[ high]
• Bc Unconjugated -1.67mg/dl [high]
• RBC Morphology – microcytic hypochromic with anisocytosis,
spherocytes
• Direct Coombs test - positive
ASSESSMENT
• Based on above subjective and objective
evidence data patient was diagnosed with
or found to be suffering from AUTO-
IMMUNE HEAMOLYTIC ANEMIA
PLANNING
GOALS OF TREATMENT
• To reduce signs and symptoms
• To correct the underlying disease
• Reduce or stop the destruction of RBCs
• To prevent relapse
• Prevent further complications like
jaundice, hepatosplenomgaly,
hyperbilirubinemia
TREATMENT OPTIONS
Tab. SHELCAL
• MOA-calcium improves
functioning of muscles,
bones and vit D3 increases
absorption of calcium and
phosphorus .
• USES – weak bone,
osteonecrosis,
hypothyroid, to maintain
healthy immune system
• SE –constipation, nausea,
vomiting, rashes
• MP- Ca++ levels, vit D3,
bone density
Tab. GEMFOS
• MOA- it is a
biphosphonate binds to
hydroxyapatite crystals in
bone & inhibits
osteoclast - mediated
bone resorption
• Uses- bone or joint pain
• SE – headache, arthralgia
constipation
• MP – Ca++ levels ,vit d &
phosphorus levela
Tab.WYSOLONE
• MOA- Prednisolone is a
steriod , modify immune
responses of body and
decreases hemolysis.
• USES- 1st line therapy for AIHA
• SE- acne, dry skin, bloating,
eye problems
• MP- BP, opthalmic exam,
blood glucose
Tab.FOLACIN
• MOA- It helps / stimulates
body to produce and
maintain blood cells
• SE- allergic rxn, fever,
bronchospasm
• USES- AIHA
• MP- Vit B12 and B9 levels
Tab.THYRONORM
• MOA-levothyroxine is synthetic form of T4, binds to thyroid
receptors in cell nucleus and causes metabolic effects
• USES-Hypothyroid
• SE-increased appetite, weight loss , headache, excessive
sweating
• MP- TSH, T4, and T3 levels
PROBLEMS IDENTIFIED
DRUG INTERACTIONS
Risedronate < > calcium ( Moderate )
• Calcium decreases effectiveness and absorption of risedronate
into systemic circulation .
• MANAGEMENT - 30 mins time gap should be there between
the administration of drugs
• Levothyroxine < > Calcium ( Moderate )
• Using calcium together with levothyroxine may decrease the
effects of levothyroxine.
• MANGEMENT : you should separate the administration of L-
thyroxine and calcium by at least 4hrs
ADR
NIL
MEDICATION
ERRORS
NIL
GOALS ACHIEVED
•B/L knee pain reduced
•No headache by the 3rd day
•No more weakness
MONITORING PARAMETERS
• Hemogoblin levels
• Hematocrit levels
• Reticulocytes levels
• Indirect bilirubin levels
• LDH levels
• ESR
• Peripheral smear
• Haptoglobin
PATIENT COUNSELLING
ABOUT THE DISEASE
• The patient must be counselled about
the disease i.e., AUTOIMMUNE
HEMOLYTIC ANEMIA which is a condition
that causes your RBCs to die sooner than
normal. And your bone marrow cannot
make new RBCs fast enough to replace
the ones that have died.
• Further the disease complications
[jaundice, hemogobinuria, arrhythmias
or cardiomyopathy ] also have to be
explained.
ABOUT MEDICATIONS
• Tab.GEMFOS -Should be taken with 1 full of glass of water,
don’t eat, lie down, bend down, for 2hrs. Can walk and sit.
• Tab.THYRONORM-should be taken morning only and a
30mins- 1hr time gap have to be maintained even to drink
water.
• There should be time gap of 30mins between CALICIUM and
RISEDRONATE.
• Parameters specific for each drug must be monitored
• Follow the medication as per the prescription
• Don’t miss the dose and double the dose if missed
• If any ADRs or SE seen report it to physician immediately.
LIFESTYLE MODIFICATIONS
• NO squatting/strains/walking on uneven surface.
• Reduce weight
• Physiotherapy should be continued
• Staying away from people who are sick and avoid large crows
of people
• Stay away from cold temperatures
• During cold weather wear a hat, scarf, & warm coat
• Take adequate amount of rest
• Avoid infections by maintain good hygiene conditions
DIET
FOODS TO BE TAKEN
• Leafy greens – [spinach, kale, broccoli] – Helps to prevent
relapse of anemia
• Meats- [chicken, beef ,ham] –useful in treating anemia
• Honey, amla juice, jack fruit & custard apple increases Hb
content in body.
• Beetroot is good remedy for treating anemia
• Banana and figs helps to stimulate production of RBC
• Enriched cereals or pastas helps to treat anemia
• Spices- including mustard seeds and ginger
FOODS TO BE AVOIDED
• Tea and coffee
• Foods that contain tannins, such as grapes, corn causes
nausea and impairs absorption of iron
• Foods rich in gluten like wheat, barley, oats – it triggers
autoimmune response and causes further complications.
• Foods that contain phytic acid like brown rice impairs
absorption of vitamins and minerals.
• Foods that contain oxalic acid such as peanuts parsely and
chocolates impair mineral absorption
REFERENCES
• Harshamohan – textbook of pathophysiology
• Drugs.com
• Medscape.com
• Healthline.com
• British journal of hematology
• The new england journal of autoimmune hemolytic anemia
autoimmune hemolytic anemia
autoimmune hemolytic anemia

More Related Content

What's hot

Paroxysmal nocturnal hemoglobinuria
Paroxysmal nocturnal hemoglobinuriaParoxysmal nocturnal hemoglobinuria
Paroxysmal nocturnal hemoglobinuria
Joselle Balasa
 
Paroxysmal Nocturnal Hemoglobinuria
Paroxysmal Nocturnal HemoglobinuriaParoxysmal Nocturnal Hemoglobinuria
Paroxysmal Nocturnal Hemoglobinuria
Debra G. Carnahan
 

What's hot (20)

Megaloblastic anemia
Megaloblastic anemiaMegaloblastic anemia
Megaloblastic anemia
 
AIHA -Autoimmune Haemolytic Anaemias
AIHA -Autoimmune Haemolytic AnaemiasAIHA -Autoimmune Haemolytic Anaemias
AIHA -Autoimmune Haemolytic Anaemias
 
Macrocytic anemia
Macrocytic anemiaMacrocytic anemia
Macrocytic anemia
 
Microcytic hypochromic anemia
Microcytic hypochromic anemiaMicrocytic hypochromic anemia
Microcytic hypochromic anemia
 
sideroblastic anemia
sideroblastic anemiasideroblastic anemia
sideroblastic anemia
 
Paroxysmal nocturnal hemoglobinuria
Paroxysmal nocturnal hemoglobinuriaParoxysmal nocturnal hemoglobinuria
Paroxysmal nocturnal hemoglobinuria
 
Sideroblastic anemia - Etiopathogenesis, Clinical features, Advances in Manag...
Sideroblastic anemia - Etiopathogenesis, Clinical features, Advances in Manag...Sideroblastic anemia - Etiopathogenesis, Clinical features, Advances in Manag...
Sideroblastic anemia - Etiopathogenesis, Clinical features, Advances in Manag...
 
Approach to microcytic hypochromic anemia
Approach to microcytic hypochromic anemiaApproach to microcytic hypochromic anemia
Approach to microcytic hypochromic anemia
 
Sideroblastic anemia
Sideroblastic anemiaSideroblastic anemia
Sideroblastic anemia
 
Autoimmune hemolytic anemia
Autoimmune hemolytic anemiaAutoimmune hemolytic anemia
Autoimmune hemolytic anemia
 
Aplastic anemia
Aplastic anemiaAplastic anemia
Aplastic anemia
 
Hemolyic Anemia ppt
Hemolyic   Anemia   pptHemolyic   Anemia   ppt
Hemolyic Anemia ppt
 
Paroxysmal nocturnal hematuria
Paroxysmal nocturnal hematuriaParoxysmal nocturnal hematuria
Paroxysmal nocturnal hematuria
 
Hemolytic anemia ppt presentation
Hemolytic anemia ppt presentationHemolytic anemia ppt presentation
Hemolytic anemia ppt presentation
 
Megaloblastic anemia
Megaloblastic anemiaMegaloblastic anemia
Megaloblastic anemia
 
autoimmune hemolytic anemia
autoimmune hemolytic anemiaautoimmune hemolytic anemia
autoimmune hemolytic anemia
 
Hemolytic Anemia
Hemolytic Anemia Hemolytic Anemia
Hemolytic Anemia
 
Paroxysmal Nocturnal Hemoglobinuria
Paroxysmal Nocturnal HemoglobinuriaParoxysmal Nocturnal Hemoglobinuria
Paroxysmal Nocturnal Hemoglobinuria
 
Approach to anemia
Approach to anemiaApproach to anemia
Approach to anemia
 
Aplastic anemia
Aplastic anemiaAplastic anemia
Aplastic anemia
 

Similar to autoimmune hemolytic anemia

Chronic Kidney Injury
Chronic Kidney InjuryChronic Kidney Injury
Chronic Kidney Injury
thommy003
 
SCA SHIVAM PPT CASE-1.pptx
SCA SHIVAM PPT CASE-1.pptxSCA SHIVAM PPT CASE-1.pptx
SCA SHIVAM PPT CASE-1.pptx
ParthMistry81
 
chemo for study day finshed_.pptx
chemo for study day finshed_.pptxchemo for study day finshed_.pptx
chemo for study day finshed_.pptx
adityasingla007
 

Similar to autoimmune hemolytic anemia (20)

ANEMIA
ANEMIAANEMIA
ANEMIA
 
MALNUTRITION IN CHILDREN.pptx
MALNUTRITION IN CHILDREN.pptxMALNUTRITION IN CHILDREN.pptx
MALNUTRITION IN CHILDREN.pptx
 
recent drugs in haematinics 2014 pharmacology
 recent drugs  in haematinics 2014 pharmacology recent drugs  in haematinics 2014 pharmacology
recent drugs in haematinics 2014 pharmacology
 
Cutaneous Manifestations of Vitamin C Deficiency
Cutaneous Manifestations of  Vitamin C Deficiency   Cutaneous Manifestations of  Vitamin C Deficiency
Cutaneous Manifestations of Vitamin C Deficiency
 
Glomerulonephritis
GlomerulonephritisGlomerulonephritis
Glomerulonephritis
 
megaloblastic anemia
megaloblastic anemiamegaloblastic anemia
megaloblastic anemia
 
Q & A FOR CLASS I.pptx
Q & A FOR CLASS I.pptxQ & A FOR CLASS I.pptx
Q & A FOR CLASS I.pptx
 
Chronic Kidney Injury
Chronic Kidney InjuryChronic Kidney Injury
Chronic Kidney Injury
 
Lupus and interstitial nephritis.pptx
Lupus and interstitial nephritis.pptxLupus and interstitial nephritis.pptx
Lupus and interstitial nephritis.pptx
 
Case presentation
Case presentationCase presentation
Case presentation
 
SCA SHIVAM PPT CASE-1.pptx
SCA SHIVAM PPT CASE-1.pptxSCA SHIVAM PPT CASE-1.pptx
SCA SHIVAM PPT CASE-1.pptx
 
ADRENAL-1.pptx
ADRENAL-1.pptxADRENAL-1.pptx
ADRENAL-1.pptx
 
Approach to a patient with hypercalcaemia
Approach to a patient with hypercalcaemiaApproach to a patient with hypercalcaemia
Approach to a patient with hypercalcaemia
 
chemo for study day finshed_.pptx
chemo for study day finshed_.pptxchemo for study day finshed_.pptx
chemo for study day finshed_.pptx
 
Leptospirosis
LeptospirosisLeptospirosis
Leptospirosis
 
Glomerulonephritis =)
Glomerulonephritis =)Glomerulonephritis =)
Glomerulonephritis =)
 
Anaemia and Polycythaemia
Anaemia and Polycythaemia Anaemia and Polycythaemia
Anaemia and Polycythaemia
 
Spleenomegaly & hypersplenism etiology pathogenesis and surgical management
Spleenomegaly & hypersplenism etiology pathogenesis and surgical managementSpleenomegaly & hypersplenism etiology pathogenesis and surgical management
Spleenomegaly & hypersplenism etiology pathogenesis and surgical management
 
Case presentation - Dengue wiith throbocytopenia.pptx
Case presentation - Dengue wiith throbocytopenia.pptxCase presentation - Dengue wiith throbocytopenia.pptx
Case presentation - Dengue wiith throbocytopenia.pptx
 
pathophysiology of rbc ( red blood cells)
pathophysiology of rbc ( red blood cells)pathophysiology of rbc ( red blood cells)
pathophysiology of rbc ( red blood cells)
 

Recently uploaded

Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
DR SETH JOTHAM
 
Mastering Wealth: A Path to Financial Freedom
Mastering Wealth: A Path to Financial FreedomMastering Wealth: A Path to Financial Freedom
Mastering Wealth: A Path to Financial Freedom
FatimaMary4
 

Recently uploaded (20)

Antiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPTAntiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPT
 
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxPT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
 
TEST BANK For Advanced Practice Nursing in the Care of Older Adults, 2nd Edit...
TEST BANK For Advanced Practice Nursing in the Care of Older Adults, 2nd Edit...TEST BANK For Advanced Practice Nursing in the Care of Older Adults, 2nd Edit...
TEST BANK For Advanced Practice Nursing in the Care of Older Adults, 2nd Edit...
 
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...Is preeclampsia and spontaneous preterm delivery associate with vascular and ...
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...
 
TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...
TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...
TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...
 
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t..."Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
 
Effects of vaping e-cigarettes on arterial health
Effects of vaping e-cigarettes on arterial healthEffects of vaping e-cigarettes on arterial health
Effects of vaping e-cigarettes on arterial health
 
Blue Printing in medical education by Dr.Mumtaz Ali.pptx
Blue Printing in medical education by Dr.Mumtaz Ali.pptxBlue Printing in medical education by Dr.Mumtaz Ali.pptx
Blue Printing in medical education by Dr.Mumtaz Ali.pptx
 
TEST BANK For Williams' Essentials of Nutrition and Diet Therapy, 13th Editio...
TEST BANK For Williams' Essentials of Nutrition and Diet Therapy, 13th Editio...TEST BANK For Williams' Essentials of Nutrition and Diet Therapy, 13th Editio...
TEST BANK For Williams' Essentials of Nutrition and Diet Therapy, 13th Editio...
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxPT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
 
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptxFinal CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
 
Contact dermaititis (irritant and allergic).pdf
Contact dermaititis (irritant and allergic).pdfContact dermaititis (irritant and allergic).pdf
Contact dermaititis (irritant and allergic).pdf
 
Aptopadesha Pramana / Pariksha: The Verbal Testimony
Aptopadesha Pramana / Pariksha: The Verbal TestimonyAptopadesha Pramana / Pariksha: The Verbal Testimony
Aptopadesha Pramana / Pariksha: The Verbal Testimony
 
Mastering Wealth: A Path to Financial Freedom
Mastering Wealth: A Path to Financial FreedomMastering Wealth: A Path to Financial Freedom
Mastering Wealth: A Path to Financial Freedom
 
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptxCURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
 
Why invest into infodemic management in health emergencies
Why invest into infodemic management in health emergenciesWhy invest into infodemic management in health emergencies
Why invest into infodemic management in health emergencies
 

autoimmune hemolytic anemia

  • 1. CASE PRESENTATION ON AUTO-IMMUNE HEMOLYTIC ANEMIA BY M.HEMA SREE PHARM D 4TH YEAR
  • 2. INTRODUCTION DEFINITION • Autoimmune hemolytic anemia[AIHA] is characterized by an abnormal production of auto antibodies[Ig G,M.E,A] that bind to Antigens on the erythrocyte surface. These antibodies then lead to destruction of RBC’s thus shortening their life span. • Red cell lifespan may decrease to 30days. CLASSIFICATION • Warm AIHA • Cold AIHA – Cold Agglutinin Syndrome Paroxysmal Cold Hemoglobinuria • Mixed type AIHA • Drug Induce Immune hemolytic anemia
  • 3. WARM AIHA • In this warm AIHA, the autoantibodies attach to & destroy the RBC at temperature ≥ to 37 degrees celcius. • More common among women. • MECHANISM OF DESTRUCTION: Due to Extravascular hemolysis • Associated with development of Ig G • May be due to primary or secondary etiology Primary – idiopathic Secondary –due to underlying disease[eg: lymphoproliferative or autoimmune disorders]
  • 4. COLD AIHA • The autoantibodies become most active and attack RBC below normal body temperature. • Mainly effects in middle aged or elderly. • Due to development of IgM & G antibody. • Either primary or secondary in etiology • MECHANSIM OF DESTRUCTION: Extravascular and Intravascular hemolysis COLD AGGLUTINATION SYNDROME – IgM antibodies • Hemolysis – extravascular • Causes – mononucleosis infections, lymphoproliferative disorders) PAROXYSMAL COLD HEMOGLOBINURIA : Ig G antiodies • Intravascular hemolysis • Occurs due to infections( sypihils, pneumoniae, measles, infulenza) also due to vaccines
  • 5.
  • 6. MIXED TYPE AIHA • Features similar to WAIHA & CAS • Both IgG & C3d[activated by IgM cold Ab] are detected DRUG INDUCED AIHA • Antibodies directed against or one of its metabolites • All may involve IgG &C3 • Eg: Pencillin , Cephalosporins , Quinidine , Methyldopa
  • 7. PATHO or IMMUNOLOGIACL VIEW • WAIA IgG binds to RBC surface antigens This drives monocytes and macrophages to grab & pick off portions of RBC membrane RBC becomes spherocytes Destructed in spleen Extravascular hemolysis
  • 8. COLD AGGLUTINATION DISEASE In cold temperature, IgM binds to polysaccharide region of glycoprotein on RBC surface This triggers complement system to lyse RBC If complement system fails to form membrane attack complex, complement proteins deposit on RBC surface This opsonisation enhances RBC phagocytosis in liver, spleen & lungs Extravascular hemolysis
  • 9. PAROXYSMALCOLD HEMOGLOBINURIA During infections , microbes trigger formation of Abs which react with p antigen of RBC surface These polyclonol anti-P autoAb binds to P-Ag of RBC in cold temp Activation of complement system, Lysis of RBCs Intravascular hemolysis
  • 10. CLINICAL MANIFESTATIONS • Paleness of skin • Fatigue • Fever and chills • Confusion • Lightheadedness • Weakness • Body ache COMMON SYPTOMS LESS COMMON SYMPTOMS • Dark urine • Yellowing of skin and eyes • Increased HR • Enlarged spleen • Enlarged liver
  • 11. DIAGNOSIS • CBC : Hb - decreased Hematocrit – decreased Reticulocytes- increased • peripheral smear – microcytic, anisocytosis , spherocytes , hypochromic , poikilocytosis • Other lab data : elevated LDH, indirect bilirubin and decreased haptoglobin • Direct coombs test
  • 12. TREATMENT WARM AHIA • Folic acid supplements • Corticosteriods like prednisolone[1- 1.5mg/kg/day] • Immunoglobulins like rituximab, azathioprine etc.. • If ineffective splenectomy considered • Blood transfusion • Splenectomy COLD AIHA • Removal of underlying disease. • Use antibiotics like pencillin in case of infections • Rituximab is given majorly • Avoid cold weather an cold drinks • Blood transfusion • Splenectomy
  • 13.
  • 15. DEMOGRAPHIC DETAILS • Patient name: XYZ • Age: 21 Years • Gender: Female • Height:165cm • Weight: 85kg • BMI: 31.2Kg/sqmm[over weight] • IP No:472890 • Dept: General medicine-554 • DOA:11/NOV/19 • DOD:14/NOV/19
  • 16. COMPLAINTS • B/L knee pain • Mild swelling at knees • Chills • Headache • Weakness and pale skin • Fatigue HISTORY • Past medical history: Hypothyroid • Past medication history: Tab Thyronorm 100mcg
  • 18. DAY TO DAY ASSESMENT DAY-1 • O/E patient conscious , coherent and afebrile • c/o bilateral knee pain, Headache(+), Generalised weakness • Hypothyroid (℞ on 1oomcg thyronorm) • No organomegaly and lymphadenopathy • Patient was evaluated outside and given Tab HCQS -400mg od 3 days • Beta thalassemia minor-negative
  • 19. Day 2 • B/L Knee pain • Weakness reduced • No other issues • T.GEMFOS[Risedronate]-35mg/week on empty stomach with 1full glass of water, Don’t EAT, LIE DOWN, BEND for 2hrs, can walk and sit Day -3 • B/L Knee pain reduced No weakness No headache • Can be discharged tomorrow
  • 20. Day -4 • DISCHARGE RECOMMENDATIONS 1. Consider treatment with biphosphonates and calcium and vitamin D - Tab SHELCAL 5OOmg OD 2. Tab GEMFOS 35mg/Week 3. Tab WYSOLONE 1.5mg/alternate day 4. No squatting, strain, inclines, walking on uneven surface 5. Reduce and maintain weight 6. Physiotherapy 7. Continue Tab THYRONORM 100mcg OD 8. Tab. FOLACIN 800mcg OD
  • 21. PHYSICAL EXAMINATION VITALS • RR -19/min • BP -110/7OmmHg • SPO2 – 98% • Respiratory system – BAE (+) No added sounds • CNS – no focal deficits • CVS –S1S2 Heard • LIMBS – distal pulses (+) • ABDOMEN – non-tender, soft
  • 22. LABORATORY VALUES PARAMETER RESULT NORMAL RANGE Haemoglobin 10.10gms% 12-16gms% RBC 3.59million/cumm 4.5-5.5 million/cumm PCV 37% 35-48% Platelets 3.63lakhs/cumm 1.5-4.5lakhs/cumm WBC 6,720cells/cumm 4k-10kcells/cumm Hematocrit 12% 37-48% Reticulocytes 3.76% 0.5-2.5% ESR 25mm 0-20mm LDH Total 197 IU/L 120-246 1U/L
  • 23. PARAMETER RESULT NORMAL RANGE T.Bilirubin 0.50mg/dl 0.1-1.2 mg/dl BC.Conjugated 0.00mg/dl 0-0.35mg/dl BC.unconjugated 0.99mg/dl 0-0.65mg/dl T.Protein 7.20g/dl 6.3-7.9g/dl Albumin 4.10g/dl 3.5-5.0g/dl Gobulin 3.10g/dl 2-3.5g/dl A/G Ratio 1.30 Approx 1 GGT 25.00 IU/L 8-62 IU/L ALP 64.OO IU/L 40-129 IU/L SGOT 26 IU/L 5-40 IU/L SGPT 23 IU/L 5-40IU/L
  • 24. IMMUNOSEROLOGY • Rheumatoid factor assay : <8.6 IU/L [ normal : <121 IU/L] PERIPHERAL SMEAR • RBC Morphology : Microcytic Hypochromic with Anisocytosis, spherocytes • WBC : normal in count & disturbances • PLATELET : Adequate BIOCHEMISTRY LUPUS ANTICOAGULANT • DIL RUSSEL VIPER VEN TIME : 58.00 sec • DRVVT CONTROL : 49.00 sec • DRVVT:DRVVTC Ratio – 1.18 sec • REFERENCE VALUE [ <1.30sec]
  • 25. URINE • Total Input- 1300ml • Total Output – 1200ml MRI OF KNEE JOINTS • Findings : few irregular areas of altered signal intensity with T1 isointense &peripheral hyperintense rim, hyperintense on T2 weighed fat • Marrow edema noted in femoral condyle with ill defined margins of sub-chondral altered signal area • Findings suggestive of medullary infracts in distal femur with sub-chondral osteonecrosis in medial femoral condyle • Mildly reduced fibro femoral joint space with reduced articular cartilage thickness[grade-2]
  • 26. MEDICATION CHART S. no BRAND NAME GENERIC NAME DOSE FREQ ROA D 1 D 2 D 3 1 T.SHELCAL Ca++ with vit D3 500mg OD PO + + + 2 T.GEMFOS Risedronate 35mg OD PO - + + 3 T. WYSOLONE Prednisolone 1.5 mg Alterna te day PO + - + 4 T.FOLACIN 800 Folic acid 800mc g OD PO + + + 5 T.THYRONOR M levothyroxine 100mc g OD PO + + +
  • 28. SUBJECTIVE EVIDENCE • Fatigue • Chills • Headache • Weakness • Pale skin
  • 29. OBJECTIVE EVIDENCE • Haemoglobin- 10.10gms% [low] • Hematocrit -12%[low] • Reticulocytes - 3.76%[ high] • Bc Unconjugated -1.67mg/dl [high] • RBC Morphology – microcytic hypochromic with anisocytosis, spherocytes • Direct Coombs test - positive
  • 30. ASSESSMENT • Based on above subjective and objective evidence data patient was diagnosed with or found to be suffering from AUTO- IMMUNE HEAMOLYTIC ANEMIA
  • 31. PLANNING GOALS OF TREATMENT • To reduce signs and symptoms • To correct the underlying disease • Reduce or stop the destruction of RBCs • To prevent relapse • Prevent further complications like jaundice, hepatosplenomgaly, hyperbilirubinemia
  • 32. TREATMENT OPTIONS Tab. SHELCAL • MOA-calcium improves functioning of muscles, bones and vit D3 increases absorption of calcium and phosphorus . • USES – weak bone, osteonecrosis, hypothyroid, to maintain healthy immune system • SE –constipation, nausea, vomiting, rashes • MP- Ca++ levels, vit D3, bone density Tab. GEMFOS • MOA- it is a biphosphonate binds to hydroxyapatite crystals in bone & inhibits osteoclast - mediated bone resorption • Uses- bone or joint pain • SE – headache, arthralgia constipation • MP – Ca++ levels ,vit d & phosphorus levela
  • 33. Tab.WYSOLONE • MOA- Prednisolone is a steriod , modify immune responses of body and decreases hemolysis. • USES- 1st line therapy for AIHA • SE- acne, dry skin, bloating, eye problems • MP- BP, opthalmic exam, blood glucose Tab.FOLACIN • MOA- It helps / stimulates body to produce and maintain blood cells • SE- allergic rxn, fever, bronchospasm • USES- AIHA • MP- Vit B12 and B9 levels
  • 34. Tab.THYRONORM • MOA-levothyroxine is synthetic form of T4, binds to thyroid receptors in cell nucleus and causes metabolic effects • USES-Hypothyroid • SE-increased appetite, weight loss , headache, excessive sweating • MP- TSH, T4, and T3 levels
  • 35. PROBLEMS IDENTIFIED DRUG INTERACTIONS Risedronate < > calcium ( Moderate ) • Calcium decreases effectiveness and absorption of risedronate into systemic circulation . • MANAGEMENT - 30 mins time gap should be there between the administration of drugs • Levothyroxine < > Calcium ( Moderate ) • Using calcium together with levothyroxine may decrease the effects of levothyroxine. • MANGEMENT : you should separate the administration of L- thyroxine and calcium by at least 4hrs
  • 37. GOALS ACHIEVED •B/L knee pain reduced •No headache by the 3rd day •No more weakness
  • 38. MONITORING PARAMETERS • Hemogoblin levels • Hematocrit levels • Reticulocytes levels • Indirect bilirubin levels • LDH levels • ESR • Peripheral smear • Haptoglobin
  • 39. PATIENT COUNSELLING ABOUT THE DISEASE • The patient must be counselled about the disease i.e., AUTOIMMUNE HEMOLYTIC ANEMIA which is a condition that causes your RBCs to die sooner than normal. And your bone marrow cannot make new RBCs fast enough to replace the ones that have died. • Further the disease complications [jaundice, hemogobinuria, arrhythmias or cardiomyopathy ] also have to be explained.
  • 40. ABOUT MEDICATIONS • Tab.GEMFOS -Should be taken with 1 full of glass of water, don’t eat, lie down, bend down, for 2hrs. Can walk and sit. • Tab.THYRONORM-should be taken morning only and a 30mins- 1hr time gap have to be maintained even to drink water. • There should be time gap of 30mins between CALICIUM and RISEDRONATE. • Parameters specific for each drug must be monitored • Follow the medication as per the prescription • Don’t miss the dose and double the dose if missed • If any ADRs or SE seen report it to physician immediately.
  • 41. LIFESTYLE MODIFICATIONS • NO squatting/strains/walking on uneven surface. • Reduce weight • Physiotherapy should be continued • Staying away from people who are sick and avoid large crows of people • Stay away from cold temperatures • During cold weather wear a hat, scarf, & warm coat • Take adequate amount of rest • Avoid infections by maintain good hygiene conditions
  • 42. DIET FOODS TO BE TAKEN • Leafy greens – [spinach, kale, broccoli] – Helps to prevent relapse of anemia • Meats- [chicken, beef ,ham] –useful in treating anemia • Honey, amla juice, jack fruit & custard apple increases Hb content in body. • Beetroot is good remedy for treating anemia • Banana and figs helps to stimulate production of RBC • Enriched cereals or pastas helps to treat anemia • Spices- including mustard seeds and ginger
  • 43.
  • 44. FOODS TO BE AVOIDED • Tea and coffee • Foods that contain tannins, such as grapes, corn causes nausea and impairs absorption of iron • Foods rich in gluten like wheat, barley, oats – it triggers autoimmune response and causes further complications. • Foods that contain phytic acid like brown rice impairs absorption of vitamins and minerals. • Foods that contain oxalic acid such as peanuts parsely and chocolates impair mineral absorption
  • 45. REFERENCES • Harshamohan – textbook of pathophysiology • Drugs.com • Medscape.com • Healthline.com • British journal of hematology • The new england journal of autoimmune hemolytic anemia